Page 23 of 33 · 771 questions tagged coa.
Concretely: 97.9% · VendorInvestigate · 96.8%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
Conditions: lot-specific certificate · SGN. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
Details up front: CPC · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Details up front: FGP · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
I have been through one internal appeal already and would like to do the next one properly. I understand the observation; what I do not understand is the mechanism…
The case in front of me: ecnoglutide · four weeks · 40 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and…
I would rather spend on verification than on volume. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
The lot number on the vial matches the certificate, which at least rules out the easy problem. The units are where I keep going wrong, so please be explicit about…
The particulars: 98.4% · a wide-pore C18 column · cagrilintide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
What I am working with: QYB · a residual-solvent screen. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that…
The particulars: 96.8% · a wide-pore C18 column · cagrilintide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
The case in front of me: sampling plan · QSC. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I have kept every message, invoice and document, which I gather is the useful habit. I am at the decision point and I would rather think it through than improvise. I…
The case in front of me: chromatogram · GGPeps. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
Details up front: QST · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
The case in front of me: purity figure · KP. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
For reference: method section · QST. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than on…
Details up front: a GLP-1 receptor agonist · six weeks · 25 °C. This is a planning question. I know what my options are; I do not know how to weigh them. What I want…
Concretely: 96.4% · VendorInvestigate · 97.9%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
Concretely: semaglutide · four weeks · 37 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
The particulars: batch certificate · ERP. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Setup, so nobody has to ask: sampling plan · ERP. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
The specifics, since they change the answer: liraglutide · ten weeks · 4 °C. I would like to define my thresholds before I have a result, for obvious reasons. I want…